1 EXHIBIT 21. SUBSIDIARIES OF THE REGISTRANT ICN Pharmaceuticals, Inc. is incorporated in the State of Delaware, and ICN Pharmaceuticals, Inc. may be deemed a parent of the Registrant. The following table, in which an indentation indicates a parent-subsidiary relationship, shows the Company's significant subsidiaries as of December 31, 1994, the percentage of their voting securities (including directors' qualifying shares) then owned by the Company or the subsidiary's immediate parent, and the jurisdiction under which each subsidiary is incorporated. These subsidiaries are included in the Company's Consolidated Financial Statements. Percentage of Voting Jurisdiction Securities Owned of by Company Incorporation or Subsidiary ------------- ------------- ICN Canada Holdings, Limited Canada 100 ICN Canada, Limited Canada 100 Alpha Pharmaceutical, Inc. Panama 100 Laboratorios Panol, S.A. de C.V. Mexico 100 ICN Farmaceutica, S.A. Mexico 100 Laboratorios Grossman, S.A. Mexico 100 ICN Pharmaceuticals Holland, B.V. Netherlands 100 Iberica, S.A. -- -- Laboratorios Hubber, S.A. Spain 100 COVOCO Holding, B.V. Netherlands 100 ICN Galenika Yugoslavia 75 ICN Biomedicals GmbH--Eschwege Germany 100 ICN Biomedicals Canada, Ltd. Canada 100 Flow Laboratories, Inc. Maryland, U.S.A. 100 ICN Biomedicals Australiasia Pty Ltd. Australia 100 ICN Biomedicals Japan Co. Ltd. Japan 100 Amstelstad A.G. Switzerland 100 ICN Biomedicals B.V. Netherlands 100 ICN Biomedicals California, Inc. California, U.S.A. 100 ICN Biomedicals, S.L. Spain 95 (Laboratorios Hubber, S.A., owns 5%) Labsystems Benelux B.V. Netherlands 100 Labsystems Benelux N.V. Belgium 100 ICN Biomedicals, Ltd. Scotland 100 ICN Biomedicals, GmbH Germany 100 Labsystems GmbH Germany 100 ICN France SARL France 100 Flow Laboratories B.V. Netherlands 100 Flow Laboratories (International) S.A. Switzerland 100 Flow Trading A.G. Switzerland 100 ICN Biomedicals S.R.L. Italy 95 (Flow Laboratories, B.V. owns 5%) ICN Biomedicals N.V./S.A. Belgium 100 In accordance with the instructions of Item 601 of Regulation S-K, certain subsidiaries are omitted from the foregoing table. 129